The GOAL Trial: Comprehensive Geriatric Assessment for Frail Older People with Chronic Kidney Disease to Increase Attainment of Patient-Identified Goals: A Cluster Randomised Controlled Trial
Doctors and researchers in the GOAL trial are studying how to improve the health and wellbeing of older frail people with chronic kidney disease (CKD).
The number of patients with CKD is increasing in Australia and worldwide. Older patients with CKD are often more frail and have complex health problems. We know that everyone has different needs and goals, and each person should get care or treatment suitable for that person.
The GOAL trial is aiming to find if a detailed medical review by a geriatrician (a specialist doctor in the care of older people) can help patients improve their health and wellbeing and achieve their goals. This detailed medical review is called a ‘Comprehensive Geriatric Assessment’.
What does the GOAL trial involve for participants?
All GOAL study participants set goals when they join the study. These goals are something that are important to participants. These goals will be reviewed at 3, 6, and 12 months. Participants also complete a short health questionnaire and frailty status check at the four study visits over 12 months.
The GOAL trial will be recruiting 500 participants across 16 hospitals in Australia. Participants from 8 sites will receive a review by a geriatrician and participants from the other 8 sites will receive their usual care. We will compare achievement of goals and health and wellbeing between the two groups. The study is now open to recruitment.
Which hospitals are taking part in the GOAL trial?
Who can take part in the study?
Adults aged over 65 years or over 55 years if Aboriginal & Torres Strait Islander with CKD stages 3 to 5 including dialysis who are current patients at participating hospitals. The study team will measure frailty status using a short test to check people can take part in the study.
To find more about this study, email email@example.com
Study team and funding
Professor Ruth Hubbard from the University of Queensland is the Principal Investigator.
Laura Robison is the Clinical Project Manager and Julie Varghese and Misa Matsuyama are Clinical Research Associates.
The National Health and Medical Research Council is funding this research.
Trial Number: AKTN 20.1
Trial Steering Committee
Consumer Advisory Board
We’d like to acknowledge and thank all the GOAL Trial Consumer Advisory Board members for their contribution and support towards the trial.